Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Study of Umbilical Cord Blood Infusion to Promote Hematopoietic and Immune System Reconstitution in Pediatric Patients With Relapsed or Refractory Malignant Solid Tumors

NCT07866534 is registered in ClinicalTrials.gov with Tianjin Medical University Cancer Institute and Hospital as lead sponsor.

NCT NCT07866534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07866534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Study of Umbilical Cord Blood Infusion to Promote Hematopoietic and Immune System Reconstitution in Pediatric Patients With Relapsed or Refractory Malignant Solid Tumors
Lead sponsor
Tianjin Medical University Cancer Institute and Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
July 31, 2028
Enrollment
10 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pediatric cancer, solid tumor cancer